All In Biotech

Free tool

FAERS Monitor: Estradiol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020538 or its brand name (Estradiol, Estradiol). Reports on generic versions are filed under their own applications.

Reports

49,280

Serious

23,503

48% of reports

Hospitalization

7,485

Death reported

922

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,108
  • headache3,056
  • nausea3,025
  • fatigue3,017
  • off label use2,458
  • pain2,204
  • diarrhoea2,023
  • dizziness1,839
  • product adhesion issue1,766
  • arthralgia1,724
  • breast cancer female1,724
  • rash1,640
  • pruritus1,634
  • dyspnoea1,593
  • hot flush1,454

Reports by year received

View as table
YearReports
2004543
2005601
2006444
20071,502
2008496
2009683
20101,067
2011964
20121,282
2013941
20141,165
20152,069
20162,638
20172,338
20182,607
20193,001
20203,034
20212,870
20223,164
20233,628
20243,783
20255,357
20265,102

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,004,879 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
breast cancer femaleSignal1,72429.428.044,237
product adhesion issueSignal1,76622.121.133,923
hot flushSignal1,4548.48.09,288
headacheSignal3,0562.12.01,770
pruritus1,6341.81.7609
arthralgia1,7241.81.7589
fatigue3,0171.71.6811
nausea3,0251.61.6769
rash1,6401.61.5383
dizziness1,8391.61.5394
pain2,2041.51.5419
diarrhoea2,0231.31.3178
drug ineffective4,1081.31.3360
dyspnoea1,5931.21.155
off label use2,4581.21.284

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.